The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune condition that can potentially affect every single organ during the course of the disease, leading to increased morbidity and mortality, and reduced health-related quality of life. While curative treatment is currently non-exist...
Main Authors: | Marcus Kai Xuan Tan, Thurston Yan Jia Heng, Anselm Mak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/4/323 |
Similar Items
-
Update on the Genetics of Systemic Lupus Erythematosus: Genome-Wide Association Studies and Beyond
by: Young-Chang Kwon, et al.
Published: (2019-09-01) -
Lupus panniculitis as an initial manifestation of systemic lupus erythematosus
by: Patel Raksha, et al.
Published: (2010-01-01) -
Laporan Kasus Cutaneus Discoid Lupus Erythematosus
by: Sarah Yunara, et al.
Published: (2017-01-01) -
The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus
by: Anselm Mak, et al.
Published: (2019-09-01) -
Vitamin D in active systemic lupus erythematosus and lupus nephritis: a forgotten player
by: Marwa K. Khairallah, et al.
Published: (2020-10-01)